Chapman, V, Markides, H, Sagar, DR, Xu, L, Burston, JJ, Mapp, P, Kay, A, Morris, RH, Kehoe, O and El Haj, AJ (2017) Therapeutic Benefit for Late, but Not Early, Passage Mesenchymal Stem Cells on Pain Behaviour in an Animal Model of Osteoarthritis. Stem Cells International, 2017. 2905104 - ?. ISSN 1687-966X

[thumbnail of A El Haj - Therapeutic benefit for late but not early passage....pdf]
Preview
Text
A El Haj - Therapeutic benefit for late but not early passage....pdf - Published Version
Available under License Creative Commons Attribution.

Download (4MB) | Preview

Abstract

Background: Mesenchymal stem cells (MSCs) have a therapeutic potential for the treatment of osteoarthritic (OA) joint pathology and pain. The aims of this study were to determine the influence of a passage number on the effects of MSCs on pain behaviour and cartilage and bone features in a rodent model of OA. Methods: Rats underwent either medial meniscal transection (MNX) or sham surgery under anaesthesia. Rats received intra-articular injection of either 1.5 × 106late passage MSCs labelled with 10 μg/ml SiMAG, 1.5 × 106late passage mesenchymal stem cells, the steroid Kenalog (200 μg/20 μL), 1.5 × 106early passage MSCs, or serum-free media (SFM). Sham-operated rats received intra-articular injection of SFM. Pain behaviour was quantified until day 42 postmodel induction. Magnetic resonance imaging (MRI) was used to localise the labelled cells within the knee joint. Results: Late passage MSCs and Kenalog attenuated established pain behaviour in MNX rats, but did not alter MNX-induced joint pathology at the end of the study period. Early passage MSCs exacerbated MNX-induced pain behaviour for up to one week postinjection and did not alter joint pathology. Conclusion: Our data demonstrate for the first time the role of a passage number in influencing the therapeutic effects of MSCs in a model of OA pain.

Item Type: Article
Additional Information: Copyright © 2017 Victoria Chapman et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Subjects: Q Science > Q Science (General)
R Medicine > R Medicine (General)
Divisions: Faculty of Medicine and Health Sciences > Institute for Science and Technology in Medicine
Related URLs:
Depositing User: Symplectic
Date Deposited: 16 Apr 2018 11:43
Last Modified: 26 Nov 2018 10:38
URI: https://eprints.keele.ac.uk/id/eprint/4764

Actions (login required)

View Item
View Item